The increased prevalence of β-lactamases in Pseudomonas aeruginosa has begun to
reduce the clinical efficacy of β-lactams against the most common opportunistic pathogen. Of …

Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …

Objectives The aim of this study was to investigate the presence of VEB enzymes among
Pseudomonas spp. referred to the UK's national reference laboratory and with phenotypic …

ABSTRACT A novel extended-spectrum β-lactamase (ESBL) was identified in a
Pseudomonas aeruginosa clinical isolate obtained from a patient admitted to a hospital in …

With the occurrence of extended-spectrum β-lactamases (ESBLs) in Pseudomonas
aeruginosa being increasingly reported worldwide, there is a need for a reliable test to …

The characterization of AmpC-type β-lactamases was performed in a collection of 32 clinical
Pseudomonas aeruginosa isolates with intermediate susceptibility or resistance to …

Extended-spectrum-lactamases capable of hydrolyzing carbapenems are increasingly being
reported for Pseudomonas aeruginosa (3). These enzymes have the broadest spectrum …

Background There are various phenotypic methods for identifying class B and class A β-
lactamase enzymes in Pseudomonas aeruginosa. The purpose of this study was to compare …

Pseudomonas aeruginosa, together with enterobacterial species, ie Enterobacter spp.,
Serratia m arcescens, Citrobacter freundii, M organella m organii and Yersinia enterocolitica …

ABSTRACT A nationwide study aimed to identify the extended-spectrum β-lactamases
(ESBLs), metallo-β-lactamases (MBLs), and extended-spectrum oxacillinases (ES-OXAs) in …